USD 0.21
(-23.88%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -1.28 USD | -417.65% |
2022 | -0.17 USD | 74.63% |
2021 | -0.67 USD | -97.06% |
2020 | -0.34 USD | 73.23% |
2019 | -1.27 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.24 USD | -14.29% |
2024 Q2 | -0.31 USD | -29.17% |
2023 Q1 | -0.22 USD | -37.5% |
2023 Q3 | -0.25 USD | -31.58% |
2023 Q2 | -0.19 USD | 13.64% |
2023 FY | - USD | -417.65% |
2023 Q4 | -0.21 USD | 16.0% |
2022 Q2 | -0.13 USD | -100.62% |
2022 Q1 | -0.06 USD | -198.63% |
2022 FY | - USD | 74.63% |
2022 Q4 | -0.16 USD | -200.0% |
2022 Q3 | 0.16 USD | 223.08% |
2021 FY | - USD | -97.06% |
2021 Q1 | -0.13 USD | -54.39% |
2021 Q4 | 0.07 USD | 178.49% |
2021 Q3 | -0.08 USD | 35.62% |
2021 Q2 | -0.13 USD | 0.0% |
2020 Q3 | -0.08 USD | 0.0% |
2020 Q1 | -0.08 USD | 73.69% |
2020 FY | - USD | 73.23% |
2020 Q4 | -0.08 USD | 0.0% |
2020 Q2 | -0.08 USD | 0.0% |
2019 Q2 | -0.32 USD | 0.0% |
2019 Q3 | -0.32 USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q1 | -0.32 USD | 0.0% |
2019 Q4 | -0.32 USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Amgen Inc. | 12.56 USD | 110.191% |
AstraZeneca PLC | 1.92 USD | 166.667% |
Biogen Inc. | 8.02 USD | 115.96% |
Gilead Sciences, Inc. | 4.54 USD | 128.194% |
MIRA Pharmaceuticals, Inc. | -0.65 USD | -96.923% |
Scilex Holding Company | -1.28 USD | -0.0% |